New findings highlight the benefit of exercise ECGs just as they are being scrapped

February 7, 2012 in Cardiology

In the UK, the exercise electrocardiogram (ECG) is the most common initial test for the evaluation of stable chest pain and has been used widely for almost half a century. However, recent NICE guidelines recommend that it should not be used to diagnose or exclude stable angina in patient assessments. New research published in the BMJ Open finds that the test has other uses that transcend its technical contribution to diagnosis.

The study, led by Professor Gene Feder from the University of Bristol, evaluated the role of exercise ECGs in 89 consultations between clinicians and patients across three chest pain clinics.

The researchers report that the functions of the exercise ECG go beyond its diagnostic function and can help clarify symptoms and other aspects of the clinical history by engaging the patient in the diagnostic process while providing a context for guidance on reversible . For example, the act of walking on the treadmill created an additional opportunity for dialogue between clinician and patient and engagement of the patient in the diagnostic process through precipitation and further elaboration of symptoms.

In addition, the exercise ECG facilitated reassurance in relation to exercise capacity and tolerance, providing a platform for behavioural and particularly when exercise was promoted by the clinician.

In patients with new onset stable chest pain, the exercise ECG has a role in articulating the clinical history through stimulating symptoms such as chest pain and , and prompting additional narrative details about their symptoms. The study suggests that through physical engagement the exercise ECG can facilitate communication between patient and clinician which, even if not improving , does enhance subsequent reassurance.

Dr Helen Cramer, the lead author, from the University's School of Social and Community Medicine, said: "As chest pain clinic services are re-configured without the test, in line with UK national (NICE) guidance, the exercise ECG will have a diminishing role in the diagnosis of angina. However, many of the practices that have been built up around the use of the exercise ECG are potentially beneficial to patients and need to be considered in the re-design of assessment services without that test. In particular, the supervised exercising of patients, even if this does not explicitly inform diagnostic decision or prognostic judgements, should form part of the assessment process."

The National Institute for Health Research (NIHR)-funded study, entitled 'Treading carefully: a qualitative ethnographic study of the clinical, social and educational uses of exercise electrocardiograms in evaluating stable chest pain' is published in the BMJ Open.

Provided by University of Bristol search and more info website

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

Second-generation TAVI device—Lotus Valve—shows good performance in REPRISE II

22 May 2013, Paris, France: The Lotus Valve, a second-generation transcatheter aortic valve implantation (TAVI) device, was successfully implanted in all of the first 60 patients in results from REPRISE II reported at EuroPCR ...

Cardiology created 12 minutes ago | popularity not rated yet | comments 0

Costs to treat stroke in America may double by 2030

Costs to treat stroke are projected to more than double and the number of people having strokes may increase 20 percent by 2030, according to the American Heart Association/American Stroke Association.

Cardiology created 23 hours ago | popularity not rated yet | comments 0

New blood-thinner measures may cut medication errors

Blood thinners are the preferred treatment option to prevent heart attacks, blood clots and stroke, but they are not without risk, and not just because of their side effects. These high-risk drugs, known as anticoagulants, ...

Cardiology created May 22, 2013 | popularity not rated yet | comments 0

Registry questions superiority of bivalirudin over heparin

Results from a large observational study reported at EuroPCR 2013 today question whether bivalirudin is superior to heparin in the absence of GPIIb/IIIa blockade, showing similar 30-day mortality in patients with non-ST segment ...

Cardiology created May 22, 2013 | popularity 5 / 5 (1) | comments 0

Study shows low rate of late lumen loss with bioresorbable DESolve device

The DESolve bioresorbable coronary scaffold system achieves good efficacy and safety with low rates of late lumen loss and major coronary adverse events at six months, show first results from the pivotal DESolve Nx trial ...

Cardiology created May 22, 2013 | popularity not rated yet | comments 0


Researchers suggest boosting body's natural flu killers

A known difficulty in fighting influenza (flu) is the ability of the flu viruses to mutate and thus evade various medications that were previously found to be effective. Researchers at the Hebrew University of Jerusalem have ...

Major human drug trial underway for Alzheimer's

A potentially ground-breaking human drug trial is currently underway, which aims to discover whether blood pressure medication can slow or halt the progression of Alzheimer's Disease (AD). This is the latest ...

Pay attention: How we focus and concentrate

Scientists at Newcastle University have shed new light on how the brain tunes in to relevant information.

New discovery in fight against deadly meningococcal disease

Professor Michael Jennings, Deputy Director of the Institute for Glycomics at Griffith University, was part of an international team that discovered the previously unknown pathway of how the bacterium colonizes people.

Are kids who take music lessons different from other kids?

(Medical Xpress)—Research by U of T Mississauga psychology professor Glenn Schellenberg reveals that two key personality traits – openness-to-experience and conscientiousness—predict better than IQ ...

Study reveals active site of enzyme linked to stuttering

(Medical Xpress)—Scientists from the Joint Center for Structural Genomics (JCSG) at SLAC National Accelerator Laboratory have determined the 3-D structure of the chemically active part of an enzyme involved ...